Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program

Bruno, S. ; Bollani, S. ; Zignego, A. L. ; Pascasio, J. M. ; Magni, C. ; Ciancio, A. ; Caremani, M. ; Mangia, A. ; Marenco, S. ; Piovesan, S. ; Chemello, L. ; Babudieri, S. ; Moretti, A. ; Gea, F. ; Colletta, C. ; Perez-Alvarez, R. ; Forns, X. ; Larrubia, J. R. ; Arenas, J. ; Crespo, J. ; Calvaruso, V. ; Ceccherini Silberstein, F. ; Maisonneuve, P. ; Craxì, A. ; Calleja, J. L.

Journal of viral hepatitis, 2015-05, Vol.22 (5), p.469-480 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível